Загрузка страницы
Все видеоНовые видеоПопулярные видеоКатегории видео

PD-L1 Testing and Developmental Process for Companion Diagnostic Tests

US Pathologist, Dr. Michael Lynch, from the Medical and Scientific Affairs (MSA) department for Roche Tissue Diagnostics discusses on:

1. The PD-L1 biomarker and its role in immunotherapy - time in video 00:50
2. Development of an FDA-approved IHC diagnostic assay - time in video 02:26
3. How to manage tissue heterogeneity - time in video 08:04
4. PD-L1 assay in clinical trial - time in video 09:14

For questions, comments, or study ideas please contact your U.S. medical and scientific affairs managers or email us at: indianapolis.msa@roche.com

TE-US-00016

Видео PD-L1 Testing and Developmental Process for Companion Diagnostic Tests канала RocheDiagnosticsUSA
Показать
Комментарии отсутствуют
Введите заголовок:

Введите адрес ссылки:

Введите адрес видео с YouTube:

Зарегистрируйтесь или войдите с
Информация о видео
14 июня 2018 г. 20:20:45
00:12:39
RocheDiagnosticsUSA
Теги
Правообладателям
Жалоба
Комментарии
Другие видео канала
Tumor Microenvironment and PD-L1 biomarkerTumor Microenvironment and PD-L1 biomarkerPD-L1 Expression on Immune and Tumor CellsPD-L1 Expression on Immune and Tumor CellsCancer Immunotherapy - PD-1 and PD-L1Cancer Immunotherapy - PD-1 and PD-L1Cancer immunotherapy | The PD-L1 pathwayCancer immunotherapy | The PD-L1 pathwayBiomarker Based Companion Diagnostics Are Enabling Precision OncologyBiomarker Based Companion Diagnostics Are Enabling Precision OncologyCancer Immunotherapy: 2020 Research Update and a Look Ahead with Dr. Padmanee SharmaCancer Immunotherapy: 2020 Research Update and a Look Ahead with Dr. Padmanee SharmaAndy, multiple myeloma survivorAndy, multiple myeloma survivorIntroduction to Immunotherapy (Immunotherapy Documentary Part I)Introduction to Immunotherapy (Immunotherapy Documentary Part I)PD-L1 Testing in Non-Small Cell Lung CarcinomaPD-L1 Testing in Non-Small Cell Lung CarcinomaHarvard i-lab | Understanding Medical Device DevelopmentHarvard i-lab | Understanding Medical Device DevelopmentPD-L1 Testing and SP142 IHC Assay as a Diagnostic Tool in Urothelial CarcinomaPD-L1 Testing and SP142 IHC Assay as a Diagnostic Tool in Urothelial CarcinomaImmune Checkpoint ProteinsImmune Checkpoint ProteinsHow to score the PD-L1 (SP263) Assay in Urothelial CarcinomaHow to score the PD-L1 (SP263) Assay in Urothelial CarcinomaNavigating the complexities of PD-L1 testingNavigating the complexities of PD-L1 testingCompanion Diagnostics Webinar RecordingCompanion Diagnostics Webinar RecordingKristin Landis-Piwowar - Molecular Diagnostics in Detection, Diagnosis, and Prognosis of CancerKristin Landis-Piwowar - Molecular Diagnostics in Detection, Diagnosis, and Prognosis of CancerStandard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern OncologyStandard and Alternative Dosing Regimens of Immunotherapies and Combinations in Modern Oncologycobas® prime Pre-analyticalSystem workflowcobas® prime Pre-analyticalSystem workflowCTLA4 and attenuation of T cell responseCTLA4 and attenuation of T cell responseRévolution du traitement du cancer par l’immunothérapie - Stéphane ChampiatRévolution du traitement du cancer par l’immunothérapie - Stéphane Champiat
Статистика портала
Яндекс.Метрика
© 2008-2024 «Информационно-развлекательный портал города Верхняя Салда»
| Карта портала | Реклама | Контакты | Сообщить об ошибке | Соглашения
salda.ws salda.ws@mail.ru
Сейчас на сайте: 512 Статистика портала